"3rd one down 12-2033 ? 'redant '"
Hi Phanto - I decided to seek an explanation from the company on exactly what this was about. Sent the following inquiry -" Justlooking for a little clarification of information on the Clinical TrialsWebsite in relation to the EFS – NCT05712161. Could you please explain what thefollowing statement means –
EstimatedStudy Completion Date:
December 2033
Is it atypo or do we monitor the trial for the next 10 years." -
and got the following response -"Thank you for your interest in Anteris.
Our Early Feasibility Study is currently in progress and we anticipateupdating the market subsequent to enrolling all patients."
Just have to wait patiently.
Cleveland Clinic has enrolled patients in EFS, page-39
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.01 |
Change
-0.390(2.53%) |
Mkt cap ! $321.3M | |||
| Open | High | Low | Value | Volume |
| $15.15 | $15.20 | $15.01 | $45.58K | 3.011K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 342 | $15.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.20 | 243 | 1 |
View Market Depth
| Last trade - 12.06pm 22/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |